Successful Use of Intraperitoneal Daptomycin in the Treatment of Vancomycin-Resistant Enterococcus Peritonitis

American Journal of Kidney Diseases

Volumn 54, Issue 3, 2009, Pages 538-541

  Huen, Sarah C ^a   Hall, Isaac ^a   Topal, Jeffrey ^a   Mahnensmith, Rex L ^a   Brewster, Ursula C ^a   Abu Alfa, Ali K ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

daptomycin; Peritoneal dialysis; peritonitis; vancomycin resistant enterococcus

Indexed keywords

CEFTAZIDIME; CIPROFLOXACIN; DAPTOMYCIN; GENTAMICIN; LINEZOLID; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; CLOSTRIDIUM DIFFICILE INFECTION; FEMALE; HUMAN; PERITONEAL DIALYSIS; PERITONITIS; RELAPSE; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ADULT; DAPTOMYCIN; ENTEROCOCCUS FAECIUM; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INJECTIONS, INTRAPERITONEAL; MIDDLE AGED; PERITONITIS; TREATMENT OUTCOME; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 68849118678     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2008.12.017     Document Type: Article

References (14)

1. Piraino B., Bailie G.R., Bernardini J., et al. Peritoneal dialysis-related infections recommendations: 2005 Update. Perit Dial Int 25 (2005) 107-131
2. Chavers L.S., Moser S.A., Benjamin W.H., et al. Vancomycin-resistant enterococci: 15 Years and counting. J Hosp Infect 53 (2003) 159-171
3. Carey H.B., Troidle L., Kliger A.S., and Finkelstein F.O. Peritonitis due to vancomycin-resistant enterococci: A case report and review of the literature. Semin Dial 12 (1999) 333-336
4. Troidle L., Kliger A.S., Gorban-Brennan N., Fikrig M., Golden M., and Finkelstein F.O. Nine episodes of CPD-associated peritonitis with vancomycin resistant enterococci. Kidney Int 50 (1996) 1368-1372
5. Lynn W.A., Clutterbuck E., Want S., et al. Treatment of CAPD-peritonitis due to glycopeptide-resistant Enterococcus faecium with quinupristin/dalfopristin. Lancet 344 (1994) 1025-1026
6. Bailey E.M., Faber M.D., and Nafziger D.A. Linezolid for treatment of vancomycin-resistant enterococcal peritonitis. Am J Kidney Dis 38 (2001) E20
7. Troidle L., Gorban-Brennan N., Kliger A.S., and Finkelstein F.O. A 5-year experience with vancomycin-resistant enterococcus peritonitis [XIXth Annual Conference on Peritoneal Dialysis Abstract]. Perit Dial Int 19 (1999) S37
8. Williams P.F. Compassionate use of synercid in the treatment of VRE peritonitis-A report of 4 cases [XIXth Annual Conference on Peritoneal Dialysis Abstract]. Perit Dial Int 19 (1999) S38
9. Schriever C.A., Fernandez C., Rodvold K.A., and Danziger L.H. Daptomycin: A novel cyclic lipopeptide antimicrobial. Am J Health Syst Pharm 62 (2005) 1145-1158
10. Carpenter C.F., and Chambers H.F. Daptomycin: Another novel agent for treating infections due to drug-resistant gram-positive infections. Clin Infect Dis 38 (2004) 994-1000
11. Salzer W. Antimicrobial-resistant gram-positive bacteria in PD peritonitis and the newer antibiotics used to treat them. Perit Dial Int 25 (2005) 313-319
12. Hermsen E.D., Hovde L.B., Hotchkiss J.R., and Rotschafer J.C. Increased killing of staphylococci and streptococci by daptomycin compared with cefazolin and vancomycin in an in vitro peritoneal dialysate model. Antimicrob Agents Chemother 47 (2003) 3764-3767
13. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing; Seventeenth Information Supplement (2007), Clinical and Laboratory Standards Institute, Wayne, PA :26(1)
14. Inman E.L., and Kirsch L.E. An improved diluent formulation for daptomycin. Patent EP0386951 (1990) inventors: LILLY CO ELI (US), assignee.